Notable Analyst Rating Changes 07/16: (GM) (BIDU) (SONS) Upgraded; (TSL) (EAT) (F) Downgraded Jul 16, 2013 10:52AM
Synta Pharma (SNTA) Sells 833K of Additional Common for $4.50/Share Jan 19, 2010 09:01AM
Synta Pharma (SNTA) Prices 5.56M Common Offering at $4.50/Share Jan 8, 2010 08:48AM
RBC Downgrades Synta Pharma (SNTA) to Sector Perform Feb 27, 2009 10:48AM
Lazard Downgrades Synta Pharma (SNTA) to Hold Feb 27, 2009 10:38AM